Lantern Pharma Statistics Share Statistics Lantern Pharma has 10.8M
shares outstanding. The number of shares has increased by 0.14%
in one year.
Shares Outstanding 10.8M Shares Change (YoY) 0.14% Shares Change (QoQ) 0.14% Owned by Institutions (%) 20.78% Shares Floating 8.2M Failed to Deliver (FTD) Shares 10,968 FTD / Avg. Volume 3.8%
Short Selling Information The latest short interest is 374.7K, so 3.47% of the outstanding
shares have been sold short.
Short Interest 374.7K Short % of Shares Out 3.47% Short % of Float 3.48% Short Ratio (days to cover) 4.93
Valuation Ratios The PE ratio is -1.65 and the forward
PE ratio is -2.04.
Lantern Pharma's PEG ratio is
0.
PE Ratio -1.65 Forward PE -2.04 PS Ratio 0 Forward PS 22.8 PB Ratio 1.62 P/FCF Ratio -1.93 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lantern Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.01,
with a Debt / Equity ratio of 0.01.
Current Ratio 0.01 Quick Ratio 0.01 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-865.88K Employee Count 24 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 9.02% in the
last 52 weeks. The beta is 1.57, so Lantern Pharma's
price volatility has been higher than the market average.
Beta 1.57 52-Week Price Change 9.02% 50-Day Moving Average 4.32 200-Day Moving Average 3.87 Relative Strength Index (RSI) 47.84 Average Volume (20 Days) 288,844
Income Statement
Revenue n/a Gross Profit -190.49K Operating Income -22.22M Net Income -20.78M EBITDA -20.59M EBIT -20.78M Earnings Per Share (EPS) -1930.92
Full Income Statement Balance Sheet The company has 7.51M in cash and 243.66K in
debt, giving a net cash position of 7.27M.
Cash & Cash Equivalents 7.51M Total Debt 243.66K Net Cash 7.27M Retained Earnings -76.03B Total Assets 17.42M Working Capital 12.32M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -17.81M
and capital expenditures -12.6K, giving a free cash flow of -17.83M.
Operating Cash Flow -17.81M Capital Expenditures -12.6K Free Cash Flow -17.83M FCF Per Share -1.66
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
